Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease-Reference-Cited by-同舟云学术

Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease

Published:2013-01 Issue:1 Volume:34 Page:1-12
ISSN:0197-4580
Container-title:Neurobiology of Aging
language:en
Short-container-title:Neurobiology of Aging

Author:

Fleisher Adam S.,Chen Kewei,Liu Xiaofen,Ayutyanont Napatkamon,Roontiva Auttawut,Thiyyagura Pradeep,Protas Hillary,Joshi Abhinay D.,Sabbagh Marwan,Sadowsky Carl H.,Sperling Reisa A.,Clark Christopher M.,Mintun Mark A.,Pontecorvo Michael J.,Coleman R. Edward,Doraiswamy P.M.,Johnson Keith A.,Carpenter Alan P.,Skovronsky Daniel M.,Reiman Eric M.

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Developmental Biology,Clinical Neurology,Ageing,General Neuroscience

Reference55 articles.

1. Frequent amyloid deposition without significant cognitive impairment among the elderly;Aizenstein;Arch. Neurol,2008

2. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease;Albert;Alzheimers Dement,2011

3. Neuropathological staging of Alzheimer-related changes;Braak;Acta Neuropathol,1991

4. Staging of Alzheimer-related cortical destruction;Braak;Int. Psychogeriatr,1997

5. Use of florbetapir-PET for imaging beta-amyloid pathology;Clark;Jama,2011

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional Glial Activation Mediates Phenotypic Effects of APOEɛ4 and Sex in Alzheimer’s Disease;Neuroglia;2024-09-05

2. The Interaction Effects of Sex, Age, APOE and Common Health Risk Factors on Human Brain Functions;2024-08-05

3. Effect of APOE ɛ4 Status on Brain Amyloid‐β and Cognitive Function in Amnestic and Nonamnestic Mild Cognitive Impairment: A [18F] Florbetapir PET‐CT Study;Advanced Therapeutics;2024-07-14

4. Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer’s Disease;Drugs;2024-06-20

5. mTOR inhibition enhances synaptic and mitochondrial function in Alzheimer’s disease in an APOE genotype-dependent manner;Journal of Cerebral Blood Flow & Metabolism;2024-06-16